Bayer could face over 45,000 glyphosate-cancer cases as settlement talks continue

yostlawrounduppage

Bayer expects the number of claims in the United States related to Roundup herbicide to have surged in the third quarter, as the German drugs and pesticides maker tries to reach a settlement after earlier court rulings against it.

“With the substantial increase in plaintiff advertising [in 2019], we expect to see a significant surge in the number of plaintiff filings over the third quarter,” the company said in a written statement.

Analysts at JP Morgan, citing an analysis of Missouri court data, said in an Oct. 9 research note that the total number of glyphosate cases could rise to more than 45,000.

Related article:  Fighting cancer with help from the body's internal clock

Bayer, which acquired Roundup and other glyphosate-based weed killers as part of its $63 billion takeover of Monsanto [in 2018], faces potentially heavy litigation costs as plaintiffs claim Roundup causes cancer, something Bayer disputes.

Read full, original article: Bayer expects significant surge in number of U.S. glyphosate cases

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: How dangerous COVID mutant strains develop

Infographic: How dangerous COVID mutant strains develop

Sometime in 2019, probably in China, SARS CoV-2 figured out a way to interact with a specific "spike" on the ...
Untitled

Philip Njemanze: Leading African anti-GMO activist claims Gates Foundation destroying Nigeria

Nigerian anti-GMO activist, physician, and inventor pushes anti-gay and anti-GMO ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend